ORAMED PHARMACEUTICALS INC. (ORMP) Net margin 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) net profit margin by fiscal year — reported net income divided by reported revenue.
3202.5%FY2025 · since FY2016: -1710.5% → 3202.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 3202.5% | — |
| FY2023 | 379.7% | +1732.3 pp |
| FY2022 | -1352.6% | -502.1 pp |
| FY2021 | -850.5% | -425.7 pp |
| FY2020 | -424.8% | +106.3 pp |
| FY2019 | -531.1% | -11.4 pp |
| FY2018 | -519.7% | -93.0 pp |
| FY2017 | -426.7% | +1283.7 pp |
| FY2016 | -1710.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ORMP financial trends
ORMP RevenueORMP Net incomeORMP Gross profitORMP Gross marginORMP Operating incomeORMP Operating marginORMP Operating cash flowORMP Free cash flowORMP Capital expendituresORMP Return on equityORMP Stock buybacksORMP Dividends paidORMP Total assetsORMP Total liabilitiesORMP Shareholders’ equityORMP overview →